Adductor Canal Block Versus Patient Controlled Analgesia, in the Surgical Stress Response for Anterior Cruciate Ligament Repair
- Conditions
- AnesthesiaSurgeryStress, Physiological
- Interventions
- Device: Morphine Patient Controlled AnalgesiaProcedure: Adductor Canal Block
- Registration Number
- NCT04797546
- Lead Sponsor
- Pontificia Universidad Catolica de Chile
- Brief Summary
To evaluate the surgical stress response in anterior cruciate ligament repair with an adductor canal block versus patient controlled endovenous analgesia.
- Detailed Description
Preoperative, 2 hours and 24 hours stress biomarkers will be evaluated in two groups of patients, continous adductor canal block and morphine patient controlled endovenous analgesia.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Male
- Target Recruitment
- Not specified
- Male,
- 18-65 years,
- traumatic Anterior Cruciate Ligament tear, scheduled for elective arthroscopic repair with Semitendinous-Gracillis technique at first time in the morning, with full articular range,
- no other traumatologic lesions.
- denied consent to participate,
- chronic steroids user,
- diabetes type 1 or 2,
- insulin resistance,
- concurrent infectious disease,
- cognitive failure, coagulopathy,
- allergy to study drugs,
- surgery scheduled in the afternoon
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Patient Controlled Morphine Analgesia Morphine Patient Controlled Analgesia Patients are placed under General Anesthesia, and after surgery, a Morphine patient controlled analgesia delivery system is installed. Preoperative, 2 hours and 24 hours stress biomarkers and analgesic quality will be measured. Adductor Canal Block Adductor Canal Block With mild sedation, a continous bupivacaine 0.1% infusion catheter is placed in the adductor canal. Afterwards, patients are placed under General Anesthesia, and surgery starts. Preoperative, 2 hours and 24 hours stress biomarkers and analgesic quality will be measured.
- Primary Outcome Measures
Name Time Method Change of Blood Cortisol from baseline to 24 hours 24 hours Blood Cortisol will be evaluated preoperatively, 2 hours and 24 hours postoperatively.
- Secondary Outcome Measures
Name Time Method Change of Glycemia from baseline to 24 hours 24 hours Glycemia will be evaluated preoperatively, 2 hours and 24 hours postoperatively.
Change of C Reactive Protein from baseline to 24 hours 24 hours C Reactive Protein will be evaluated preoperatively, 2 hours and 24 hours postoperatively.
Trial Locations
- Locations (1)
Pontificia Universidad Católica de Chile
🇨🇱Santiago, Chile